Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-04-06, Stock:JNJ, The news for the past five days is as follows:
2018-03-29: NEWS1: Geron Corp. Skyrocketed and AbbVie Inc. Crashed -- Are These Stocks Buys?.NEWS2: Arkansas sues opioid manufacturers for roles in epidemic.NEWS3: JNJ INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Johnson & Johnson and a Lead Plaintiff Deadline of April 9, 2018.NEWS4: Tackle Market Uncertainty With These 3 Quality Dividend ETFs.NEWS5: Tackle Market Uncertainty With These 3 Quality Dividend ETFs.NEWS6: Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Johnson & Johnson Investors (JNJ).NEWS7: Eli Lilly’s Segment-by-Segment Performance in 4Q17.NEWS8: What’s Merck’s Valuation in March 2018?.NEWS9: How Is Novartis’s Cosentyx Positioned after 4Q17?.NEWS10: A Look at Bristol-Myers Squibb’s Eliquis in 4Q17.NEWS11: What Analysts Recommend for Merck in March 2018.NEWS12: Eli Lilly and Company’s Valuation in March 2018.NEWS13: The Zacks Analyst Blog Highlights: Johnson & Johnson, Intel, Procter & Gamble, Caterpillar and Halliburton.NEWS14: The Zacks Analyst Blog Highlights: Johnson & Johnson, Intel, Procter & Gamble, Caterpillar and Halliburton.NEWS15: These 3 Biotech Stocks Are Soaring, but Are They Buys Now?.NEWS16: Incyte Could Have a Problem (or 2!) on Its Hands.NEWS17: How Merck Stock Has Performed Recently.NEWS18: The Zacks Analyst Blog Highlights: Johnson & Johnson, Intel, Procter & Gamble, Caterpillar and Halliburton.
2018-04-02: NEWS1: U.S. Justice Department seeks role in opioid settlement talks.NEWS2: Why I Won&apos;t Buy Ethereum.NEWS3: DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Johnson & Johnson and Encourages Investors to Contact The Firm.NEWS4: Why Geron Corporation Stock Is Falling Today.NEWS5: Why Geron Corporation Stock Is Falling Today.NEWS6: EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Johnson & Johnson of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 9, 2018 - JNJ.NEWS7: How an ill-advised tweet became a nightmare for a Fox News show.NEWS8: iShares Russell 1000 ETF Experiences Big Outflow.NEWS9: iShares Russell 1000 ETF Experiences Big Outflow.NEWS10: Why Geron Corporation Stock Is Falling Today.NEWS11: Shire's Stock Continues to Rise as Takeda Sets Eyes On it.NEWS12: Shire's Stock Continues to Rise as Takeda Sets Eyes On it.NEWS13: How Novartis’s Alcon Performed in 4Q17 and Fiscal 2017.NEWS14: How Novartis’s Alcon Performed in 4Q17 and Fiscal 2017.NEWS15: How Eli Lilly’s Neuroscience Products Performed in 4Q17.NEWS16: How Eli Lilly’s Neuroscience Products Performed in 4Q17.NEWS17: How Did Sandoz Perform in 4Q17 and Fiscal 2017?.NEWS18: How Did Sandoz Perform in 4Q17 and Fiscal 2017?.NEWS19: Are Short-Sellers Right About Geron Corporation?.NEWS20: Are Short-Sellers Right About Geron Corporation?.NEWS21: Are Short-Sellers Right About Geron Corporation?.
2018-04-03: NEWS1: Pfizer Reportedly In Talks With P&G On Consumer Business Sale.NEWS2: Pfizer Reportedly In Talks With P&G On Consumer Business Sale.NEWS3: The 10 Best Stocks to Buy for April.NEWS4: The 10 Best Stocks to Buy for April.NEWS5: IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Johnson & Johnson And Reminds Investors To Contact The Firm.NEWS6: Johnson & Johnson Stock on March 29, 2018.NEWS7: Markets Right Now: Late rally sends US stock indexes higher.NEWS8: The Klein Law Firm Notifies Investors of Commencement of a Class Action Filed on Behalf of Johnson & Johnson Shareholders and a Lead Plaintiff Deadline of April 9, 2018 (JNJ).NEWS9: Markets Right Now: Stocks move solidly higher on Wall Street.NEWS10: Markets Right Now: Stocks move solidly higher on Wall Street.NEWS11: Pfizer in talks with P&G for consumer health unit sale - CNBC.NEWS12: The brand boycott of Laura Ingraham’s Fox News show barely registers with consumers.NEWS13: The brand boycott of Laura Ingraham’s Fox News show barely registers with consumers.NEWS14: Pfizer in talks with P&G on sale of its consumer business, though they are far apart on price: Sources.NEWS15: Pfizer in talks with P&G on sale of its consumer business, though they are far apart on price: Sources.NEWS16: Pfizer in talks with P&G for consumer health unit sale - CNBC.NEWS17: What Analysts Recommend for Novartis in March 2018.NEWS18: What Analysts Recommend for Novartis in March 2018.NEWS19: Will These Drugs Reach Blockbuster Status?.NEWS20: Will These Drugs Reach Blockbuster Status?.NEWS21: April 9th Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Johnson & Johnson (JNJ).
2018-04-04: NEWS1: 5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Johnson & Johnson And Reminds Investors To Contact The Firm.NEWS2: EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Johnson & Johnson of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 9, 2018 – JNJ.NEWS3: NYSE trader: Here are the real risks to the U.S. economy.NEWS4: Allergan's Vraylar Meets Endpoints in Bipolar I Phase III.NEWS5: Allergan's Vraylar Meets Endpoints in Bipolar I Phase III.NEWS6: AstraZeneca's (AZN) Bydureon Gets FDA Nod for Expanded Use.NEWS7: AstraZeneca's (AZN) Bydureon Gets FDA Nod for Expanded Use.NEWS8: Johnson & Johnson’s Quarterly Revenue Trend in 2017.NEWS9: J&J Jury Set to Weigh Banker's Claims Baby Powder Caused Cancer.NEWS10: Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for April 05, 2018.NEWS11: Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for April 05, 2018.NEWS12: Johnson & Johnson’s Valuation in March 2018.NEWS13: Which Big Pharma CEOs Least Deserved Their Big Pay Increases?.NEWS14: Which Big Pharma CEOs Least Deserved Their Big Pay Increases?.NEWS15: Analysts’ Recommendations for Johnson & Johnson in March 2018.NEWS16: Which Big Pharma CEOs Least Deserved Their Big Pay Increases?.NEWS17: The boycott of Laura Ingraham’s Fox News show barely registered with consumers (with one exception).NEWS18: The boycott of Laura Ingraham’s Fox News show barely registered with consumers (with one exception).NEWS19: Smith & Nephew Names Namal Nawana CEO - Quick Facts.NEWS20: Smith & Nephew Names Namal Nawana CEO - Quick Facts.
2018-04-05: NEWS1: Corrected: J&J loses trial over claims linking cancer to asbestos in talc.NEWS2: UPDATE 2-J&J loses trial over claims linking cancer to asbestos in talc.NEWS3: J&J Ordered to Pay $37 Million Over Banker's Talc Cancer Claims.NEWS4: J&J Must Pay Millions Over Banker's Baby Powder Cancer Claim.NEWS5: J&J Ordered to Pay $37 Million Over Banker's Talc Cancer Claims.NEWS6: FDA Refuses Alkermes Depression Drug Review: 4 Stocks in Focus.NEWS7: FDA Refuses Alkermes Depression Drug Review: 4 Stocks in Focus.NEWS8: Wall Street Brushes Off Trade War Fears: Top 5 Gainers.NEWS9: Wall Street Brushes Off Trade War Fears: Top 5 Gainers.NEWS10: FDA Refuses Alkermes Depression Drug Review: 4 Stocks in Focus.NEWS11: 5 Dividend Growth Stocks With Upside To Analyst Targets.NEWS12: 5 Dividend Growth Stocks With Upside To Analyst Targets.NEWS13: 3 Emerging Technologies Set to Transform the Pharma World.NEWS14: Johnson & Johnson’s Business Segments in 2017.NEWS15: Alkermes' Bad News Could Be Good News for Johnson & Johnson.NEWS16: Alkermes' Bad News Could Be Good News for Johnson & Johnson.NEWS17: Alkermes&apos; Bad News Could Be Good News for Johnson & Johnson.

Answer: Decrease